Key references: Approach to prophylaxis for migraine and drugs used

  • Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn) 2015;21(4 Headache):973–89. https://www.ncbi.nlm.nih.gov/pubmed/26252585
  • Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016;86(19):1818–26. https://www.ncbi.nlm.nih.gov/pubmed/27164716
  • Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003;289(1):65–9. https://www.ncbi.nlm.nih.gov/pubmed/12503978